A2 Biotherapeutics, Inc. raised $80M Series C venture round, led by Samsara BioCapital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
The Column GroupLEAD | Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$208.5M
Top Valuation
-
A2 Biotherapeutics, Inc. raised $80M in a Series C round.
The round was announced on 01/09/25.
The round was led by Samsara BioCapital, The Column Group.